Inhalable Formulation Based on Lipid–Polymer Hybrid Nanoparticles for the Macrophage Targeted Delivery of Roflumilast

[Image: see text] Here, novel lipid–polymer hybrid nanoparticles (LPHNPs), targeted to lung macrophages, were realized as potential carriers for Roflumilast administration in the management of chronic obstructive pulmonary disease (COPD). To achieve this, Roflumilast-loaded fluorescent polymeric nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Craparo, Emanuela F., Cabibbo, Marta, Scialabba, Cinzia, Giammona, Gaetano, Cavallaro, Gennara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364311/
https://www.ncbi.nlm.nih.gov/pubmed/35899612
http://dx.doi.org/10.1021/acs.biomac.2c00576

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364311/
https://www.ncbi.nlm.nih.gov/pubmed/35899612
http://dx.doi.org/10.1021/acs.biomac.2c00576

Ejemplares similares